On the other hand, the SCMC-pAML HR group showed a trend of worse prognosis compared to the ELN HR group, with 5-year EFS rates of 18.2% (95% CI 12.0–27.7%) vs. 30.9% (95% CI 21.8–43.7%), without a statistical difference (log-rank test, P = 0.40).
← all excerpts
Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification.
1
—
—